ϰϲͼ Pediatric Hematology/Oncology/Blood and Marrow Transplant Research
The Division of Hematology/Oncology/Blood and Marrow has a long-standing commitment to basic and translation research that stems from the work carried out in our basic science laboratories, participation in co-operative group trials, as well as in epidemiology and outcomes research
Meet Our Research Faculty
Kristin Bingen, PhD
“My research interests include psychosocial functioning and health-related quality of life of childhood cancer survivors of adolescents and young adults, as well as transitional care of adolescents and young adults with cancer.”
Amanda Brandow, DO
“My clinical research lab is focused on investigating the underlying neurobiology of pain in patients with sickle cell disease. My interest in pain research has also expanded beyond sickle cell disease to studying neuropathic pain in children with cancer who have received neurotoxic chemotherapy.”
Meghen Browning, MD
“My research interests include novel local control modalities for sarcoma, adolescent and young adult sarcoma care, and cellular therapies for solid tumors, especially neuroblastoma.”
Michael J. Burke, MD
My research interests are focused on the development of early phase clinical trials involving novel agents and/or combination therapies for relapsed/refractory hematologic neoplasms.”
William Drobyski, MD
“My research interests focus on the immunobiology of allogeneic stem cell transplantation. Specifically, I am interested in the pathophysiology of graft versus host disease, pro inflammatory cytokine dysregulation, the immunotherapy of cancer, and immune reconstitution.”
Veronica Flood, MD
“My research is focused on the coagulation protein von Willebrand factor and its interactions with ligands, including platelets and collagen. My laboratory studies the molecular biology of von Willebrand factor, with an interest in mutations and sequence variations, and their effect on protein function.”
Paul Harker-Murray, MD, PhD
“My research interests are in clinical trials of pediatric patients with relapsed and refractory Hodgkin lymphoma; nanoliposomal irinotecan and cyclophosphamide for relapsed solid tumors; and quality improvement in pediatric hematology, oncology, bone marrow transplant.”
Jennifer Hoag, PhD
“My research interests include family adjustment, psychosocial outcomes of bone marrow/peripheral stem cell donation, and school re-integration.”
David A. Margolis, MD
“My research interests are focused on the treatment of children with severe aplastic anemia as well as allogeneic hematopoietic progenitor cell transplant for children with malignant and non-malignant disorders.”
Jeffrey A. Medin, PhD
"My research is focused on ameliorating acquired and inherited disorders by way of gene therapy. My laboratory develops novel chimeric antigen receptor and bispecific antibody-based immunotherapies and studies the pathophysiology and treatment of inherited monogenic diseases."
Learn more about the Medin Lab below.
Robert Montgomery, MD
“My research interests are: clinical and molecular studies on 650 subject USA VWD cohort; tests to define VWF functions; gene therapy of hemophilia; a through ectopic expression of FVIII in platelets; and the role of VWF pathology in cardiopulmonary bypass in neonates with complex congenital heart disease.”
Rowena Punzalan, MD
“My research interests are in pediatric thrombosis and anticoagulation, and pediatric transfusion medicine.”
Sridhar Rao, MD, PhD
“The overall goal of my laboratory is to understand how transcription factors and epigenetic pathways regulate the unique properties of stem cells, whether they are embryonic stem cells, adult stem cells, or cancer stem cells.”
Qizhen Shi, MD, PhD
“My research interest is in hemophilia.”
Fritz Sieber, PhD
“My research interests are in preclinical development of novel selenium-based anti-cancer agents with emphasis on proteinated subnano particles of elemental selenium. Selenium-based interventions for the prevention and mitigation of therapy-induced toxicities with emphasis on radiation- and chemotherapy-induced hearing loss and cognitive defects.”
Julie-An Talano, MD
“My research interests are in alternative bone marrow transplantation for hematologic malignancies and non-malignant disorders and Phase I Cytotoxic T cells for immune reconstitution post transplantation. I am currently the Director of Clinical Research in Bone Marrow Transplantation.”
Richard L. Tower, II, MD, MS
“My research interest is in the effects of leukemia therapies, communication with patients and families, and medical education.”
David Wilcox, PhD
“My research interests are in hematopoietic stem cell gene therapy aimed using platelets to correct inherited bleeding disorder. The goal of my research is to utilize hematopoietic stem cells as a target for gene therapy for common and rare inherited bleeding disorders.“
About Pediatric Hematology/Oncology Research
Jeffrey A. Medin, PhD Research Lab
ϰϲͼ | Department of Pediatrics: Section of Hematology/Oncology/BMT
Contact the Medin Lab
Jeffrey A Medin, PhD
Professor, Pediatrics (Hematology/Oncology); Secondary Faculty
(414) 955-4118
Mary Faber, PhD
Lab Manager
(414) 955-5771